VKTX – 30-Min Long Trade Setup!📈 🟢
🔹 Asset: Viking Therapeutics, Inc. (VKTX – NASDAQ)
🔹 Timeframe: 30-Min Chart
🔹 Setup Type: Symmetrical Triangle Breakout + Retest
📊 Trade Plan – Long Position
✅ Entry Zone: $23.60 (Breakout confirmation above triangle resistance)
✅ Stop-Loss (SL): $22.50 (Below structure & trendline support)
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.065 EUR
−106.22 M EUR
0.00 EUR
108.99 M
About Viking Therapeutics, Inc.
Sector
Industry
CEO
Brian Lian
Website
Headquarters
San Diego
Founded
2012
FIGI
BBG01TNXKZW2
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
VKTX – 15-Min Long Trade Setup!📈 🟢
🔹 Asset: Viking Therapeutics, Inc. (VKTX – NASDAQ)
🔹 Timeframe: 15-Min Chart
🔹 Setup Type: Symmetrical Triangle Breakout + Retest
📊 Trade Plan – Long Position
✅ Entry Zone: $22.21 (Breakout confirmation above yellow zone)
✅ Stop-Loss (SL): $21.38 (Below rising trendline + structural base)
🎯 Ta
VKTX: Support Levels to Watch A double bottom formed in early March, leading to a strong bounce above $30. Since then, the stock has pulled back into the mid-$20s. Given current market conditions and the chart setup, a retest of S-1 at $24.50 looks likely. If that level breaks, S-2 at $17.96 comes into play as the next key suppo
Viking Rejecting This Price LevelBefore testing the $30 region, Viking is likely to retest the descending trendline around $34. This move could represent a 10% gain in the short term.
If the descending trendline breaks, the next potential target would be $44, signaling a strong bullish continuation. Keep an eye on price action and
VKTX: Potential Double Bottom? VKTX bounced off $24.50, testing a key support level that could confirm a double bottom if it holds. If it breaks down, I expect a move toward $21, a longer-term support level I’ve been watching and where I may consider stepping in with cash-secured puts once it stabilizes. Let's see where it trades
$VKTXyieahhh
We can go touch $46 and potentially go test the upper part of the channel.
Bunch of confluences for the bounce.
1. Parallel channel support
2. Wave C has same length as Wave A
2. Filled previous gap
3. Using previous high from 2023 as support
4. Weekly RSI and MACD turning around
Daily RS
VKTX: Bullish Divergence Leading to a Reversal?Viking Therapeutics has been in a downtrend since late 2024, with price consistently making lower lows. However, since mid January, 2025, both the Relative Strength Index (RSI) and Stochastic Momentum Index (SMI) have been sloping upward, diverging from the price action, which continued to trend low
VIKING - To Crash, Or To Explode?VTV Therapeutics (VKTX) is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapies to treat metabolic diseases. The company primarily targets areas such as non-alcoholic steatohepatitis (NASH), type 2 diabetes, and other metabolic disorders. Here's a
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
The current price of 1VKTX is 24.115 EUR — it has decreased by −2.86% in the past 24 hours. Watch VIKING THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange VIKING THERAPEUTICS INC stocks are traded under the ticker 1VKTX.
1VKTX stock has fallen by −1.26% compared to the previous week, the month change is a 10.19% rise, over the last year VIKING THERAPEUTICS INC has showed a 6.37% increase.
We've gathered analysts' opinions on VIKING THERAPEUTICS INC future price: according to them, 1VKTX price has a max estimate of 110.00 EUR and a min estimate of 26.40 EUR. Watch 1VKTX chart and read a more detailed VIKING THERAPEUTICS INC stock forecast: see what analysts think of VIKING THERAPEUTICS INC and suggest that you do with its stocks.
1VKTX reached its all-time high on May 2, 2025 with the price of 26.345 EUR, and its all-time low was 22.670 EUR and was reached on Apr 25, 2025. View more price dynamics on 1VKTX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1VKTX stock is 3.59% volatile and has beta coefficient of 1.19. Track VIKING THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is VIKING THERAPEUTICS INC there?
Today VIKING THERAPEUTICS INC has the market capitalization of 2.67 B, it has increased by 7.74% over the last week.
Yes, you can track VIKING THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
VIKING THERAPEUTICS INC is going to release the next earnings report on Jul 23, 2025. Keep track of upcoming events with our Earnings Calendar.
1VKTX earnings for the last quarter are −0.38 EUR per share, whereas the estimation was −0.30 EUR resulting in a −25.00% surprise. The estimated earnings for the next quarter are −0.40 EUR per share. See more details about VIKING THERAPEUTICS INC earnings.
VIKING THERAPEUTICS INC revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
1VKTX net income for the last quarter is −42.18 M EUR, while the quarter before that showed −34.21 M EUR of net income which accounts for −23.28% change. Track more VIKING THERAPEUTICS INC financial stats to get the full picture.
No, 1VKTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 7, 2025, the company has 36 employees. See our rating of the largest employees — is VIKING THERAPEUTICS INC on this list?
Like other stocks, 1VKTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIKING THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.